Lord, S. R., & Harris, A. L. (2023). Is it still worth pursuing the repurposing of metformin as a cancer therapeutic? British journal of cancer, 128(6), 958-966. https://doi.org/10.1038/s41416-023-02204-2
Chicago-Zitierstil (17. Ausg.)Lord, Simon R., und Adrian L. Harris. "Is It Still Worth Pursuing the Repurposing of Metformin as a Cancer Therapeutic?" British Journal of Cancer 128, no. 6 (2023): 958-966. https://doi.org/10.1038/s41416-023-02204-2.
MLA-Zitierstil (9. Ausg.)Lord, Simon R., und Adrian L. Harris. "Is It Still Worth Pursuing the Repurposing of Metformin as a Cancer Therapeutic?" British Journal of Cancer, vol. 128, no. 6, 2023, pp. 958-966, https://doi.org/10.1038/s41416-023-02204-2.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.